Literature DB >> 1859056

Predictive value of oropharyngeal cultures for identifying lower airway bacteria in cystic fibrosis patients.

B W Ramsey1, K R Wentz, A L Smith, M Richardson, J Williams-Warren, D L Hedges, R Gibson, G J Redding, K Lent, K Harris.   

Abstract

Identifying lower respiratory pathogens in young, non expectorating cystic fibrosis (CF) patients has been problematic. Bronchial secretions are difficult to obtain, and little is known about lower airway flora in these patients. We collected simultaneous bronchial and oropharyngeal specimens in 43 CF patients in optimal respiratory status, including both expectorating (17) and nonexpectorating (26) patients, to determine the predictive value of oropharyngeal cultures for identifying lower airway pathogens. An additional goal was to characterize the lower respiratory flora of these patients. Predictive values were defined as the proportion of oropharyngeal culture results that accurately reflected the results of bronchial cultures. Predictive values of positive oropharyngeal cultures in nonexpectorating patients were 83% (95% confidence interval 36 to 100%) for Pseudomonas aeruginosa and 91% (59 to 100%) for Staphylococcus aureus. Predictive values of negative oropharyngeal cultures were lower: 70% (48 to 86%) for R aeruginosa and 80% (52 to 96%) for S. aureus. A relatively high proportion of nonexpectorating CF patients less than 10 yr old had R aerusginosa (11 of 24, 46%) or Klebsiella species (5 of 24, 21%) in their lower airways. The isolation of Klebsiella was associated with younger age (p = 0.03) and recent administration of antistaphylococcal antibiotics (p = 0.05). Our results suggest that oropharyngeal cultures yielding R aeruginosa or S. aureus are highly predictive, but such cultures lacking these organisms do not rule out the presence of these pathogens in the lower airways of CF patients.

Entities:  

Mesh:

Year:  1991        PMID: 1859056     DOI: 10.1164/ajrccm/144.2.331

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  39 in total

1.  Pulmonary exacerbations in cystic fibrosis with negative bacterial cultures.

Authors:  Edith T Zemanick; Brandie D Wagner; J Kirk Harris; Jeffery S Wagener; Frank J Accurso; Scott D Sagel
Journal:  Pediatr Pulmonol       Date:  2010-06

2.  Bronchoscopy following diagnosis with cystic fibrosis.

Authors:  Tom N Hilliard; Seema Sukhani; Jacqueline Francis; Neil Madden; Mark Rosenthal; Ian Balfour-Lynn; Andrew Bush; Jane C Davies
Journal:  Arch Dis Child       Date:  2006-11-06       Impact factor: 3.791

3.  Utility of gram stain in evaluation of sputa from patients with cystic fibrosis.

Authors:  E Sadeghi; A Matlow; I MacLusky; M A Karmali
Journal:  J Clin Microbiol       Date:  1994-01       Impact factor: 5.948

Review 4.  Clinical significance of microbial infection and adaptation in cystic fibrosis.

Authors:  Alan R Hauser; Manu Jain; Maskit Bar-Meir; Susanna A McColley
Journal:  Clin Microbiol Rev       Date:  2011-01       Impact factor: 26.132

5.  Sputum induction improves detection of pathogens in children with cystic fibrosis.

Authors:  Jordana E Hoppe; Elinor Towler; Brandie D Wagner; Frank J Accurso; Scott D Sagel; Edith T Zemanick
Journal:  Pediatr Pulmonol       Date:  2015-01-07

6.  Associations between Gut Microbial Colonization in Early Life and Respiratory Outcomes in Cystic Fibrosis.

Authors:  Anne G Hoen; Jing Li; Lisa A Moulton; George A O'Toole; Molly L Housman; Devin C Koestler; Margaret F Guill; Jason H Moore; Patricia L Hibberd; Hilary G Morrison; Mitchell L Sogin; Margaret R Karagas; Juliette C Madan
Journal:  J Pediatr       Date:  2015-03-26       Impact factor: 4.406

7.  Treatments for preventing recurrence of infection with Pseudomonas aeruginosa in people with cystic fibrosis.

Authors:  Sally Palser; Sherie Smith; Edward F Nash; Arnav Agarwal; Alan R Smyth
Journal:  Cochrane Database Syst Rev       Date:  2019-12-17

8.  Pseudomonas aeruginosa and cystic fibrosis: Antibiotic therapy and the science behind the magic.

Authors:  N E Macdonald
Journal:  Can J Infect Dis       Date:  1997-11

9.  Secretory IgA-mediated immune response in saliva and early detection of Pseudomonas aeruginosa in the lower airways of pediatric cystic fibrosis patients.

Authors:  Renan Marrichi Mauch; Claudio Lucio Rossi; Marcos Tadeu Nolasco da Silva; Talita Bianchi Aiello; José Dirceu Ribeiro; Antônio Fernando Ribeiro; Niels Høiby; Carlos Emilio Levy
Journal:  Med Microbiol Immunol       Date:  2019-01-31       Impact factor: 3.402

10.  Impact of Pseudomonas and Staphylococcus infection on inflammation and clinical status in young children with cystic fibrosis.

Authors:  Scott D Sagel; Ronald L Gibson; Julia Emerson; Sharon McNamara; Jane L Burns; Jeffrey S Wagener; Bonnie W Ramsey
Journal:  J Pediatr       Date:  2008-09-25       Impact factor: 4.406

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.